bpc 157 human clinical trials safety dosing bpc-157 dosage BPC-157 (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Dosage: A Complete Guide
Description
Key nutritional features include maintaining already healthy cholesterol and blood sugar levels, promoting GI microbial balance, and supporting healthy metabolism
It delivers copper to lysyl oxidase, the enzyme responsible for cross-linking collagen types I and III into durable, organized fibers
It is not approved by any regulatory authority for human use
Abstract BPC 157, a pentadecapeptide derived from human gastric juice, has been demonstrated to promote the healing of different tissues, including skin, muscle, bone, ligament and tendon in many animal studies
